Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302197 · ClinicalTrials.gov registry record
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
A clinical trial of Stroke, sponsored by Baltimore VA Medical Center.
- Active
- Registry status
- 100
- Enrollment target
- 3
- Study locations
NCT01302197: Active study of Stroke, sponsored by Baltimore VA Medical Center.
NCT01302197 is a study of Stroke that is active but no longer recruiting, run by Baltimore VA Medical Center. The registered enrollment target is 100 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01302197, a study of Stroke, is active but no longer recruiting, sponsored by Baltimore VA Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
Stroke, a leading cause of disability in the aging population, increases the risk for diabetes, subsequent stroke recurrence, and cardiovascular disease complications. The downsizing of private and federal health care resources, along with the anticipated increase in stroke rates as our population ages, mandate that alternative strategies be developed to reduce the public health burden of stroke. This pilot study may facilitate our knowledge of the timing of paretic leg muscle atrophy, fiber type shift, and the progression of worsening of glucose tolerance after stroke. Knowledge of the skeletal muscle changes occurring in the sub-acute stroke period is essential to create new guidelines incorporating exercise rehabilitation, much like cardiac rehabilitation, in order to facilitate and improve the health care of veteran stroke survivors.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (3)
Maryland
- University of Maryland Medical System - Baltimore
- VA Maryland Health Care System, Baltimore - Baltimore
- Kernan Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-04-13 |
| Est. Completion | 2026-06 |
What the registry record for NCT01302197 still lists
NCT01302197 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT01302197 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01302197 about?
NCT01302197 is a clinical study titled "Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke". Stroke, a leading cause of disability in the aging population, increases the risk for diabetes, subsequent stroke recurrence, and cardiovascular disease complications. The downsizing of private and federal health care resources, along with the anticipated increase in stroke rates as our population a...
What is the current status of trial NCT01302197?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2011-04-13. Estimated completion is 2026-06.
What conditions does trial NCT01302197 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT01302197?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01302197?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01302197 being conducted?
This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01302197's enrollment target sits among peer trials
100 135th of 454 higher than 309 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI